The Next Big Thing in Biotech: Pfizer
Senior columnist Adam Feuerstein says Pfizer is the next big thing in biotech.
Biotech Stock Mailbag: Exelixis, Protalix, Arena
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.
Will Apple's Stock Become Dead Money?
Any objective look at investing in AAPL has to consider alternatives.
Mason's Maturity; Houston's Problem; Einhorn's Interrogation; Rupert Gets Rocked; Aubrey's Apology. Challenger: Not Enough Growth to Create Jobs
John Challenger of Challenger Grey & Christmas believes the headwinds are too strong to see job growth like we saw at the beginning of the year. Business in Revenue Mode? You May Not Need Bank Loan
The top 10 open-market insider purchases and sales filed at the SEC Wednesday. When Volkswagen Entered China
In a new book, a German wise man recalls how VW shunted Chrysler aside in China. 401(k) Day Trading Turns a Happy 4
TheStreet Guest Contributor
Even with trouble lurking at nearly every turn, 401(k) day trading took my precious cargo to the next level. Dow Falls More Than 100 Points
The Dow tumbles after the government reports that only 115,000 jobs were added in the U.S. last month. Now Hiring ... Ninjas?
There are many ways for a company to position itself as innovative, but now even job titles are in play.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV